Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation Research

• Publication date

  2015-06-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.116.304494PMID 26044252PMCID PMC4676576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induced pluripotent stem cells.

  2015cited by this paper
• Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.

  2014cited by this paper
• Development and applications of CRISPR-Cas9 for genome engineering.

  2014cited by this paper
• Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy

  2014cited by this paper
• International Conference on Harmonisation

  2014cited by this paper
• Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.

  2014cited by this paper
• Cardiac regeneration using pluripotent stem cells--progression to large animal models.

  2014cited by this paper
• Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium.

  2014cited by this paper
• The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes.

  2014cited by this paper
• Whole-cell patch-clamp recording of recombinant voltage-sensitive Ca2+ channels heterologously expressed in HEK-293 cells.

  2014cited by this paper
• The generation of the epicardial lineage from human pluripotent stem cells

  2014cited by this paper
• Development and Applications of CRISPR-Cas 9 for Genome Engineering

  2014cited by this paper
• Rapid Cellular Phenotyping of Human Pluripotent Stem Cell-Derived Cardiomyocytes using a Genetically Encoded Fluorescent Voltage Sensor

  2014cited by this paper
• Cardiac safety assays.

  2014cited by this paper
• Human Stem Cells for Modeling Heart Disease and for Drug Discovery

  2014cited by this paper
• Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.

  2014influential reference
• Routes to induced pluripotent stem cells.

  2014cited by this paper
• Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.

  2013cited by this paper
• A history of the role of the hERG channel in cardiac risk assessment.

  2013cited by this paper
• Automated planar patch-clamp.

  2013cited by this paper
• Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs

  2013cited by this paper
• Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

  2013influential reference
• Multi-electrode array technologies for neuroscience and cardiology.

  2013cited by this paper
• Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.

  2013cited by this paper
• Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays

  2013cited by this paper
• Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment

  2013influential reference
• Postnatal Overfeeding Causes Early Shifts in Gene Expression in the Heart and Long-Term Alterations in Cardiometabolic and Oxidative Parameters

  2013cited by this paper
• Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture.

  2013cited by this paper
• Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery

  2013cited by this paper
• Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics

  2013cited by this paper
• Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets

  2013cited by this paper
• Patient-specific stem cells and cardiovascular drug discovery.

  2013cited by this paper
• New directions in antiarrhythmic drug therapy for atrial fibrillation.

  2013cited by this paper
• Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials

  2013cited by this paper
• A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening, and Publication Standards

  2013cited by this paper
• MicroRNA regulation of cardiac conduction and arrhythmias.

  2013cited by this paper
• Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.

  2013cited by this paper
• Pros and cons of screening for sudden cardiac death in sports

  2013cited by this paper
• ESICM 2013 - Abstracts of Oral Presentations and Poster Sessions

  2013cited by this paper
• Modeling Timothy Syndrome with iPS Cells

  2013cited by this paper
• Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets.

  2013cited by this paper
• Intracoronary Delivery of Autologous Cardiac Stem Cells Improves Cardiac Function in a Porcine Model of Chronic Ischemic Cardiomyopathy

  2013cited by this paper
• Electrical Stimulation Promotes Maturation of Cardiomyocytes Derived from Human Embryonic Stem Cells

  2013cited by this paper
• Drug-induced arrhythmia: pharmacogenomic prescribing?

  2013cited by this paper
• HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

  2013cited by this paper
• Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype.

  2013cited by this paper
• Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.

  2013influential reference
• Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays.

  2013cited by this paper
• A Large Candidate Gene Survey Identifies the KCNE1 D85N Polymorphism as a Possible Modulator of Drug-Induced Torsades de Pointes

  2012cited by this paper
• Isolation, Characterization, and Spatial Distribution of Cardiac Progenitor Cells in the Sheep Heart.

  2012cited by this paper
• Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich’s ataxia

  2012cited by this paper
• Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation

  2012cited by this paper
• Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias

  2012cited by this paper
• β-Adrenergic Stimulation Increases Cav3.1 Activity in Cardiac Myocytes through Protein Kinase A

  2012cited by this paper
• Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

  2012cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Clinical and Genetic Determinants of Torsade de Pointes Risk

  2012cited by this paper
• Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy

  2012cited by this paper
• Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease

  2012cited by this paper
• Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.

  2012cited by this paper
• Cardiac G-Protein–Coupled Receptor Kinase 2 Ablation Induces a Novel Ca2+ Handling Phenotype Resistant to Adverse Alterations and Remodeling After Myocardial Infarction

  2012cited by this paper
• Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation

  2012cited by this paper
• Disease characterization using LQTS-specific induced pluripotent stem cells.

  2012cited by this paper
• Optical Imaging of Voltage and Calcium in Cardiac Cells & Tissues

  2012cited by this paper
• Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.

  2012cited by this paper
• An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment.

  2012cited by this paper
• Organotypic slice culture from human adult ventricular myocardium.

  2012cited by this paper
• Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia

  2012cited by this paper
• Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

  2012cited by this paper
• Quantitative comparison of cardiac ventricular myocyte electrophysiology and response to drugs in human and nonhuman species.

  2012cited by this paper
• Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells.

  2011cited by this paper
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

  2011cited by this paper
• Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome

  2011cited by this paper
• Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.

  2011cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Sudden Cardiac Arrest Without Overt Heart Disease

  2011cited by this paper
• High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

  2011cited by this paper
• In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells

  2011cited by this paper
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

  2011influential reference
• Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

  2011cited by this paper
• Stem Cells and Their Derivatives: A Renaissance in Cardiovascular Translational Research

  2011cited by this paper
• Large animal models for cardiac stem cell therapies.

  2011cited by this paper
• Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

  2011cited by this paper
• Modelling the long QT syndrome with induced pluripotent stem cells

  2011cited by this paper
• Induced Pluripotent Stem Cells

  2011cited by this paper
• Market withdrawal of new molecular entities approved in the United States from 1980 to 2009

  2011cited by this paper
• Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk

  2011cited by this paper
• A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity

  2011cited by this paper
• Increasing Cardiac Contractility After Myocardial Infarction Exacerbates Cardiac Injury and Pump Dysfunction

  2010cited by this paper
• Composite Cell Sheets: A Further Step Toward Safe and Effective Myocardial Regeneration by Cardiac Progenitors Derived From Embryonic Stem Cells

  2010cited by this paper
• Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals

  2010cited by this paper
• Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome

  2010cited by this paper
• GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice.

  2010cited by this paper
• Cardiac ion channels in health and disease.

  2010cited by this paper
• Enhanced basal contractility but reduced excitation-contraction coupling efficiency and beta-adrenergic reserve of hearts with increased Cav1.2 activity.

  2010cited by this paper
• Electrocardiographic assessment for therapeutic proteins--scientific discussion.

  2010cited by this paper
• Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes.

  2010cited by this paper
• The benefits and limitations of animal models for translational research in neurodegenerative diseases

  2010cited by this paper
• New antiarrhythmic drugs for treatment of atrial fibrillation.

  2010cited by this paper
• Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

  2010cited by this paper
• Microelectronic system for high-resolution mapping of extracellular electric fields applied to brain slices.

  2009cited by this paper
• Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)

  2009cited by this paper

• Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases

  2025cites this paper
• Assaying the myosin super-relaxed state across muscle types, cells and proteins for understanding muscle biology and use in drug discovery.

  2025cites this paper
• Clinical trials in-a-dish for cardiovascular medicine.

  2024cites this paper
• In vitro to in vivo extrapolation from three-dimensional hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment.

  2024cites this paper
• Increased Epicardial Adipose Tissue and Heart Characteristics Are Correlated with BMI and Predict Silent Myocardial Infarction in Sudden Cardiac Death Subjects: An Autopsy Study

  2023cites this paper
• Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome

  2023cites this paper
• Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes

  2023cites this paper
• Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome

  2023cites this paper
• Repeated and On-Demand Intracellular Recordings of Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells

  2022cites this paper
• Clinical Trial in a Dish for Space Radiation Countermeasure Discovery.

  2022cites this paper
• Beyond Pharmaceuticals: Fit-for-Purpose New Approach Methodologies for Environmental Cardiotoxicity Testing

  2022cites this paper
• Cellular and Engineered Organoids for Cardiovascular Models

  2022cites this paper
• Characterizing arrhythmia using machine learning analysis of Ca2+ cycling in human cardiomyocytes

  2022cites this paper
• The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome

  2022cites this paper
• Ventricular voltage‐gated ion channels: Detection, characteristics, mechanisms, and drug safety evaluation

  2021cites this paper
• Genetics of Sudden Cardiac Death, the Channelopathies: Today's Perspective and the Future

  2021cites this paper
• Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity

  2020cites this paper
• Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine

  2020cites this paper
• Establishment of a heart-on-a-chip microdevice based on human iPS cells for the evaluation of human heart tissue function

  2020cites this paper
• Inherited Ventricular Arrhythmias, the Channelopathies and SCD: Current Knowledge and Future Speculations - Risk Stratification, Management Plans and Future Speculations

  2020cites this paper
• Specific recognition of ion channel blocker by high-content cardiomyocyte electromechanical integrated correlation.

  2020cites this paper
• Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.

  2020cites this paper
• KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity

  2020cites this paper
• hiPSCs Derived Cardiac Cells for Drug and Toxicity Screening and Disease Modeling: What Micro- Electrode-Array Analyses Can Tell Us

  2019cites this paper
• Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls and potential

  2019cites this paper
• Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes

  2019cites this paper
• Sudden Cardiac Death in Dialysis: Arrhythmic Mechanisms and the Value of Non-invasive Electrophysiology

  2019influential citation
• The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs.

  2019cites this paper
• A computational model of induced pluripotent stem‐cell derived cardiomyocytes incorporating experimental variability from multiple data sources

  2019cites this paper
• Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.

  2019cites this paper
• A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation

  2018cites this paper
• 25 – Stem Cell–Derived Sinoatrial-Like Cardiomyocytes as a Novel Pharmacological Tool

  2018cites this paper
• Probing flecainide block of INa using human pluripotent stem cell-derived ventricular cardiomyocytes adapted to automated patch-clamping and 2D monolayers.

  2018cites this paper
• A Simple ImageJ-Based Method to Measure Cardiac Rhythm in Zebrafish Embryos

  2018cites this paper
• The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system.

  2018cites this paper
• Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization

  2018cites this paper
• Many Cells Make Life Work—Multicellularity in Stem Cell-Based Cardiac Disease Modelling

  2018cites this paper
• Generation and customization of biosynthetic excitable tissues for electrophysiological studies and cell-based therapies

  2018cites this paper
• HCN4 Gene Polymorphisms and Tachycardia-Induced Cardiomyopathy: True or Spurious Association?

  2018cites this paper
• Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential

  2018cites this paper
• Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)

  2017cites this paper
• Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics

  2017cites this paper
• Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue

  2017cites this paper
• In vitro models of the cardiac microenvironment to study myocyte and non‐myocyte crosstalk: bioinspired approaches beyond the polystyrene dish

  2017cites this paper
• Recent advances in understanding and prevention of sudden cardiac death

  2017cites this paper
• Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes

  2017influential citation
• Engineering Cardiac Muscle Tissue: A Maturating Field of Research.

  2017cites this paper
• Heart-on-a-Chip Model for Cardiomyopathies

  2017cites this paper
• Sudden death: Neurogenic causes, prediction and prevention

  2017cites this paper
• Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy.

  2017cites this paper
• The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system.

  2017cites this paper
• Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

  2016cites this paper
• Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.

  2016cites this paper
• Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia

  2016cites this paper
• Induced pluripotent stem cells: at the heart of cardiovascular precision medicine

  2016cites this paper
• A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells

  2016cites this paper
• Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

  2016cites this paper
• Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.

  2016cites this paper
• Molecular Basis of Functional Myocardial Potassium Channel Diversity.

  2016cites this paper
• Reprogramming human peripheral blood mononuclear cells to inducible pluripotent stem cells (hiPSC): An examination of the efficacy of different methods

  2016cites this paper
• Laminar ventricular myocardium on a microelectrode array-based chip.

  2016cites this paper
• Current Status of Genome Editing in Cardiovascular Medicine

  2016cites this paper
• Human Pluripotent Stem Cell‐Derived Cardiomyocytes

  2016cites this paper
• Stem Cell Proteomics

  2016cites this paper
• Differentiation of hiPSC-Derived Cardiomyocytes

  2016cites this paper
• Diversity and functional roles of K + channels in cardiac repolarization : from single cell to whole organ levels

  2016cites this paper
• Actual strategies in human induced pluripotent stem cells ( hiPSCs ) differentiation – perspectives and challenges

  2016cites this paper
• Contribution of Automated Technologies to Ion Channel Drug Discovery.

  2016cites this paper
• Tracking and Quantification of Magnetically Labeled Stem Cells Using Magnetic Resonance Imaging

  2016cites this paper
• Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.

  2016cites this paper
• Joseph C. Wu: Envisioning Personalized Medicine and Clinical Trials in a Dish.

  2015cites this paper
• Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.

  2015cites this paper
• Introduction to a compendium on sudden cardiac death: epidemiology, mechanisms, and management.

  2015cites this paper
• Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?

  2015cites this paper
• Recent advances in understanding and prevention of sudden cardiac death [version 1; peer review: 2 approved]

  year unknowncites this paper